80P Expanded access program use of ripretinib in advanced GIST patients in the United Kingdom von Napolitano, A., Lim, S.Y., Ferro Lopez, L.F., Benson, C., Jones, R.L.

Volltext

88P Real-world evidence of the efficacy of ipilimumab plus nivolumab in patients with epithelioid sarcoma von Mavroeidis, L., Lopez, L.F. Ferro, Pozas, J., D'Arienzo, P.D., Wall, A., Napolitano, A., Benson, C., Thway, K., Jones, R.L.

Volltext

87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience von Zhang, S.H., Cartwright, E., Mullings, S., Ferro Lopez, L.F., Cunningham, D., Chau, I., Starling, N., Popat, S., O'Brien, M.E.R., Bhosle, J., Minchom, A.R., Davidson, M., Tokaca, N., Lalondrelle, S., Pickering, L.M., Furness, A., Turajlic, S., Larkin, J., José, R., Young, K.

Volltext